33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeted therapy-induced senescence enhances immune surveillance of KRAS mutant lung cancers
    Meeting Abstract

    Ruscetti, M.; Leibold, J.; Bott, M. J.; Shields, M.; Chen, C. C.; Fennell, M.; Chen, H. C.; Baslan, T.; Salgado, N. R.; Manchado, E.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Cancer modeling in the CRISPR age
    Meeting Abstract

    Ventura, A.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Treatment-free remission (TFR) in patients with chronic-phase chronic myeloid leukemia (CML-CP) with stable deep molecular response (DMR) discontinuing dasatinib (DASFREE)
    Meeting Abstract

    Shah, N. P.; Garcia-Gutierrez, J. V.; Jimenez-Velasco, A.; Larson, S.; Saussele, S.; Rea, D.; Mahon, F. X.; Levy, M. Y.; Gomez-Casares, M. T.; Pane, F.; more...
    British Journal of Haematology (2018)

    Fulltext@MSK | Save
  • Efficacy and safety of first-line bosutinib versus imatinib in the BFORE trial: 18-month follow-up
    Meeting Abstract

    Clark, R. E.; Gambacorti-Passerini, C.; Deininger, M.; Mauro, M. J.; Chuah, C.; Kim, D. W.; Dyagil, I.; Glushko, N.; Milojkovic, D.; Le Coutre, P.; more...
    British Journal of Haematology (2018)

    Fulltext@MSK | Save
  • A validated risk model for overall survival in relapsed/refractory chronic lymphocytic leukaemia applicable to patients treated with novel therapies and standard of care
    Meeting Abstract

    Hillmen, P.; Soumerai, J.; Zelenetz, A.; Darif, M.; Londhe, A.; Xing, G.; Huang, J.; Lin, M.; Byrd, J.; Chanan-Khan, A.; more...
    British Journal of Haematology (2018)

    Fulltext@MSK | Save
  • Venetoclax (VEN) in patients with relapsed/refractory non-Hodgkin lymphoma (NHL)
    Meeting Abstract

    Davids, M.; Roberts, A.; Seymour, J.; Wierda, W.; Puvvada, S.; Gressick, L.; Alter, D.; Zhou, L.; Kim, S.; Verdugo, M.; more...
    British Journal of Haematology (2018)

    Fulltext@MSK | Save
  • Risk factors for grade 3/4 transaminase elevation in patients with chronic lymphocytic leukaemia treated with idelalisib
    Meeting Abstract

    Hillmen, P.; Brown, J.; Zelenetz, A.; Furman, R.; Lamanna, N.; Mato, A.; Montillo, M.; O'Brien, S.; Dreiling, L.; Dubowy, R.; more...
    British Journal of Haematology (2018)

    Fulltext@MSK | Save
  • Neutrophil-to-lymphocyte ratio as a predictor of invasive carcinoma in patients with intraductal papillary mucinous neoplasms of the pancreas
    Meeting Abstract

    McIntyre, C. A.; Lawrence, S. A.; Pulvirenti, A.; Seier, K.; Gonen, M.; D'Angelica, M.; Kingham, P.; Balachandran, V.; Drebin, J.; Jarnagin, W.; more...
    Annals of Surgical Oncology (2018)

    Fulltext@MSK | Save
  • Adjuvant hepatic artery infusion chemotherapy after resection of colorectal liver metastases is associated with improved survival in patients with both right and left-sided primary tumors
    Meeting Abstract

    Gholami, S.; Kemeny, N.; Gonen, M.; Cercek, A.; Kingham, P.; Balachandran, V.; Allen, P.; DeMatteo, R.; Jarnagin, W.; D'Angelica, M.
    Annals of Surgical Oncology (2018)

    Fulltext@MSK | Save
  • Near infrared intraoperative imaging with second window indocyanine green can improve visualization of pancreatic neoplasms during distal pancreatectomy
    Meeting Abstract

    Newton, A. D.; Predina, J. D.; Connolly, C. T.; Shin, M. T.; Frenzel-Sulyok, L.; Drebin, J.; Singhal, S.; Lee, M. K. 4th
    Annals of Surgical Oncology (2018)

    Fulltext@MSK | Save